Abstract:To utilize metabolomics in conjunction with RNA sequencing to identify biomarkers in the blood of sepsis patients and discover novel targets for diagnosing and treating sepsis. In January 2019 and December 2020, blood samples were collected from a cohort of 16 patients diagnosed with sepsis and 11 patients diagnosed with systemic inflammatory response syndrome (SIRS). Non-targeted metabolomics analysis was conducted using liquid chromatography coupled with mass spectrometry (LC–MS/MS technology), while gene sequencing was performed using RNA sequencing. Afterward, the metabolite data and sequencing data underwent quality control and difference analysis, with a fold change (FC) greater than or equal to 2 and a false discovery rate (FDR) less than 0.05.Co-analysis was then performed to identify differential factors with consistent expression trends based on the metabolic pathway context; KEGG enrichment analysis was performed on the crossover factors, and Meta-analysis of the targets was performed at the transcriptome level using the public dataset. In the end, a total of five samples of single nucleated cells from peripheral blood (two normal controls, one with systemic inflammatory response syndrome, and two with sepsis) were collected and examined to determine the cellular location of the essential genes using 10× single cell RNA sequencing (scRNA-seq). A total of 485 genes and 1083 metabolites were found to be differentially expressed in the sepsis group compared to the SIRS group. Among these, 40 genes were found to be differentially expressed in both the metabolome and transcriptome. Functional enrichment analysis revealed that these genes were primarily involved in biological processes related to inflammatory response, immune regulation, and amino acid metabolism. Furthermore, a meta-analysis identified four genes, namely ITGAM, CD44, C3AR1, and IL2RG, which were highly expressed in the sepsis group compared to the normal group ( P < 0.05). Additionally, scRNA-seq analysis revealed that the core genes ITGAM and C3AR1 were predominantly localized within the macrophage lineage. The primary genes ITGAM and C3AR1 exhibit predominant expression in macrophages, which play a significant role in inflammatory and immune responses. Moreover, these genes show elevated expression levels in the plasma of individuals with sepsis, indicating their potential as valuable subjects for further research in sepsis.

Characterization of Mirnas Circulating in Sepsis Patients' Serum

Accuracy of Circulating Micrornas in Diagnosis of Sepsis: a Systematic Review and Meta-Analysis

Characterization and Identification of Novel Serum Micrornas in Sepsis Patients with Different Outcomes

Four Serum Micrornas Identified As Diagnostic Biomarkers of Sepsis

MicroRNAs in Sepsis

Identification of MicroRNA as Sepsis Biomarker Based on miRNAs Regulatory Network Analysis

Serum Microrna Signatures Identified by Solexa Sequencing Predict Sepsis Patients' Mortality: a Prospective Observational Study.

MicroRNA as Sepsis Biomarkers: A Comprehensive Review

Circulating microRNAs as biomarkers for Sepsis secondary to pneumonia diagnosed via Sepsis 3.0

Diagnostic Potential of Plasma Extracellular Vesicle Mir-483-3p and Let-7d-3p for Sepsis.

Identification of potential biomarkers and pathways for sepsis using RNA sequencing technology and bioinformatic analysis

Serum miR-126-3p level is down-regulated in sepsis patients

Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis

Exosome‐Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis

MicroRNAs combined with the TLR4/TDAG8 mRNAs and proinflammatory cytokines are biomarkers for the rapid diagnosis of sepsis

Differential Expression Profile of Long Non-Coding RNAs from Gr-1+ CD11b+ Myeloid Cells in Response to Sepsis in Mice (INM2P.424)

Evidence for Serum Mir-15a and Mir-16 Levels As Biomarkers That Distinguish Sepsis from Systemic Inflammatory Response Syndrome in Human Subjects

Comprehensive Transcriptome Profiling of Peripheral Blood Mononuclear Cells from Patients with Sepsis

MicroRNAs as Potential Diagnostic New Biomarkers in Diagnosis of Sepsis in Pediatric Patients

Urinary Micrornas in Sepsis Function As a Novel Prognostic Marker.

Identification and validation of key biomarkers based on RNA methylation genes in sepsis